Irritable Bowel Syndrome

Participant Criteria:

  • Study evaluating the safety and effects of two doses of JNJ-27018966 versus placebo in patients with Irritable Bowel Syndrome with diarrhea (IBS-d).
  • Adults 18 years to 80 years of age.
  • Thirteen study visits during the 13 month trial duration.

If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button or call Gina Kavanaugh at (757) 969-5885.